Skip to main content
Top
Published in: European Journal of Nutrition 5/2020

01-08-2020 | Insulins | Original Contribution

Pre-meal protein intake alters postprandial plasma metabolome in subjects with metabolic syndrome

Authors: Ceyda Tugba Pekmez, Ann Bjørnshave, Giulia Pratico, Kjeld Hermansen, Lars Ove Dragsted

Published in: European Journal of Nutrition | Issue 5/2020

Login to get access

Abstract

Purpose

We examined the effect on the postprandial plasma metabolome of protein pre-meals before a fat-rich main meal.

Methods

Two randomized, cross-over meal studies were conducted to test the dose–response effect (0 g, 10 g, 20 g) of a pre-meal with whey protein (WP) (PREMEAL I), and the effect of protein quality (10 g WP, casein, or gluten) and timing (− 15 min vs − 30 min) of the pre-meal (PREMEAL II). Participants with metabolic syndrome received one of the test meals on each test day, − 15 min (or − 30 min) prior to a standardized fat-rich breakfast. Plasma samples were collected at − 15 min (or − 30 min), 0, 120, 240 a nd 360 min and analyzed using liquid chromatography–mass spectrometry with an untargeted method.

Results

Pre-meal WP intake elevated plasma branched-chain amino acids (BCAA), aromatic amino acids and methionine and decreased plasma LPC (16:0) and PC (32:1) levels before the main meal. Early (− 15 to 0 min) aromatic amino acids and BCAA in response to pre-meal WP partially predict the glucose and insulin response after the main meal. A pre-meal with WP altered the postprandial plasma metabolic pattern of acyl-carnitines, specific PCs, LPCs and LPEs, betaine, citric acid, linoleic acid, and β-hydroxypalmitic acid compared to no pre-meal. The casein and WP pre-meals exhibited similar postprandial amino acid responses whereas a pre-meal with gluten resulted in lower levels of plasma amino acids and its metabolites.

Conclusion

A pre-meal with protein affects the postprandial metabolic pattern indicating facilitated glucose and lipid disposal from plasma in participants with metabolic syndrome.
Appendix
Available only for authorised users
Literature
1.
go back to reference Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr (2009) Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120(16):1640–1645. https://doi.org/10.1161/circulationaha.109.192644 CrossRefPubMed Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr (2009) Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120(16):1640–1645. https://​doi.​org/​10.​1161/​circulationaha.​109.​192644 CrossRefPubMed
18.
go back to reference Chen T, Guestrin C (2016) XGBoost: A Scalable Tree Boosting System. In: Paper presented at the Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining, San Francisco, California, USA Chen T, Guestrin C (2016) XGBoost: A Scalable Tree Boosting System. In: Paper presented at the Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining, San Francisco, California, USA
19.
go back to reference Bergstra J, Bengio Y (2012) Random search for hyper-parameter optimization. J Mach Learn Res 13:281–305 Bergstra J, Bengio Y (2012) Random search for hyper-parameter optimization. J Mach Learn Res 13:281–305
21.
go back to reference Storey JD (2002) A direct approach to false discovery rates. J R Stat Soc Ser B (Statistical Methodology) 64(3):479–498CrossRef Storey JD (2002) A direct approach to false discovery rates. J R Stat Soc Ser B (Statistical Methodology) 64(3):479–498CrossRef
24.
go back to reference Sumner LW, Amberg A, Barrett D, Beale MH, Beger R, Daykin CA, Fan TWM, Fiehn O, Goodacre R, Griffin JL, Hankemeier T, Hardy N, Harnly J, Higashi R, Kopka J, Lane AN, Lindon JC, Marriott P, Nicholls AW, Reily MD, Thaden JJ, Viant MR (2007) Proposed minimum reporting standards for chemical analysis Chemical Analysis Working Group (CAWG) Metabolomics Standards Initiative (MSI). Metabolomics 3(3):211–221. https://doi.org/10.1007/s11306-007-0082-2 CrossRefPubMedPubMedCentral Sumner LW, Amberg A, Barrett D, Beale MH, Beger R, Daykin CA, Fan TWM, Fiehn O, Goodacre R, Griffin JL, Hankemeier T, Hardy N, Harnly J, Higashi R, Kopka J, Lane AN, Lindon JC, Marriott P, Nicholls AW, Reily MD, Thaden JJ, Viant MR (2007) Proposed minimum reporting standards for chemical analysis Chemical Analysis Working Group (CAWG) Metabolomics Standards Initiative (MSI). Metabolomics 3(3):211–221. https://​doi.​org/​10.​1007/​s11306-007-0082-2 CrossRefPubMedPubMedCentral
25.
go back to reference King DG, Walker M, Campbell MD, Breen L, Stevenson EJ, West DJ (2018) A small dose of whey protein co-ingested with mixed-macronutrient breakfast and lunch meals improves postprandial glycemia and suppresses appetite in men with type 2 diabetes: a randomized controlled trial. Am J Clin Nutr 107(4):550–557. https://doi.org/10.1093/ajcn/nqy019 CrossRefPubMed King DG, Walker M, Campbell MD, Breen L, Stevenson EJ, West DJ (2018) A small dose of whey protein co-ingested with mixed-macronutrient breakfast and lunch meals improves postprandial glycemia and suppresses appetite in men with type 2 diabetes: a randomized controlled trial. Am J Clin Nutr 107(4):550–557. https://​doi.​org/​10.​1093/​ajcn/​nqy019 CrossRefPubMed
29.
go back to reference Shah SH, Crosslin DR, Haynes CS, Nelson S, Turer CB, Stevens RD, Muehlbauer MJ, Wenner BR, Bain JR, Laferrère B, Gorroochurn P, Teixeira J, Brantley PJ, Stevens VJ, Hollis JF, Appel LJ, Lien LF, Batch B, Newgard CB, Svetkey LP (2012) Branched-chain amino acid levels are associated with improvement in insulin resistance with weight loss. Diabetologia 55(2):321–330. https://doi.org/10.1007/s00125-011-2356-5 CrossRefPubMed Shah SH, Crosslin DR, Haynes CS, Nelson S, Turer CB, Stevens RD, Muehlbauer MJ, Wenner BR, Bain JR, Laferrère B, Gorroochurn P, Teixeira J, Brantley PJ, Stevens VJ, Hollis JF, Appel LJ, Lien LF, Batch B, Newgard CB, Svetkey LP (2012) Branched-chain amino acid levels are associated with improvement in insulin resistance with weight loss. Diabetologia 55(2):321–330. https://​doi.​org/​10.​1007/​s00125-011-2356-5 CrossRefPubMed
31.
go back to reference Inubushi T, Kamemura N, Oda M, Sakurai J, Nakaya Y, Harada N, Suenaga M, Matsunaga Y, Ishidoh K, Katunuma N (2012) l-tryptophan suppresses rise in blood glucose and preserves insulin secretion in type-2 diabetes mellitus rats. J Nutr Sci Vitaminol 58(6):415–422CrossRefPubMed Inubushi T, Kamemura N, Oda M, Sakurai J, Nakaya Y, Harada N, Suenaga M, Matsunaga Y, Ishidoh K, Katunuma N (2012) l-tryptophan suppresses rise in blood glucose and preserves insulin secretion in type-2 diabetes mellitus rats. J Nutr Sci Vitaminol 58(6):415–422CrossRefPubMed
34.
go back to reference Floegel A, Stefan N, Yu Z, Mühlenbruch K, Drogan D, Joost H-G, Fritsche A, Häring H-U, Hrabě de Angelis M, Peters A, Roden M, Prehn C, Wang-Sattler R, Illig T, Schulze MB, Adamski J, Boeing H, Pischon T (2013) Identification of serum metabolites associated with risk of Type 2 diabetes using a targeted metabolomic approach. Diabetes 62(2):639CrossRefPubMedPubMedCentral Floegel A, Stefan N, Yu Z, Mühlenbruch K, Drogan D, Joost H-G, Fritsche A, Häring H-U, Hrabě de Angelis M, Peters A, Roden M, Prehn C, Wang-Sattler R, Illig T, Schulze MB, Adamski J, Boeing H, Pischon T (2013) Identification of serum metabolites associated with risk of Type 2 diabetes using a targeted metabolomic approach. Diabetes 62(2):639CrossRefPubMedPubMedCentral
37.
go back to reference Kim JY, Park JY, Kim OY, Ham BM, Kim H-J, Kwon DY, Jang Y, Lee JH (2010) Metabolic profiling of plasma in overweight/obese and lean men using ultra performance liquid chromatography and Q-TOF mass spectrometry (UPLC–Q-TOF MS). J Proteome Res 9(9):4368–4375. https://doi.org/10.1021/pr100101p CrossRefPubMed Kim JY, Park JY, Kim OY, Ham BM, Kim H-J, Kwon DY, Jang Y, Lee JH (2010) Metabolic profiling of plasma in overweight/obese and lean men using ultra performance liquid chromatography and Q-TOF mass spectrometry (UPLC–Q-TOF MS). J Proteome Res 9(9):4368–4375. https://​doi.​org/​10.​1021/​pr100101p CrossRefPubMed
48.
go back to reference Mihas C, Kolovou GD, Mikhailidis DP, Kovar J, Lairon D, Nordestgaard BG, Ooi TC, Perez-Martinez P, Bilianou H, Anagnostopoulou K, Panotopoulos G (2011) Diagnostic value of postprandial triglyceride testing in healthy subjects: a meta-analysis. Curr Vasc Pharmacol 9(3):271–280CrossRefPubMed Mihas C, Kolovou GD, Mikhailidis DP, Kovar J, Lairon D, Nordestgaard BG, Ooi TC, Perez-Martinez P, Bilianou H, Anagnostopoulou K, Panotopoulos G (2011) Diagnostic value of postprandial triglyceride testing in healthy subjects: a meta-analysis. Curr Vasc Pharmacol 9(3):271–280CrossRefPubMed
Metadata
Title
Pre-meal protein intake alters postprandial plasma metabolome in subjects with metabolic syndrome
Authors
Ceyda Tugba Pekmez
Ann Bjørnshave
Giulia Pratico
Kjeld Hermansen
Lars Ove Dragsted
Publication date
01-08-2020
Publisher
Springer Berlin Heidelberg
Keywords
Insulins
Insulins
Published in
European Journal of Nutrition / Issue 5/2020
Print ISSN: 1436-6207
Electronic ISSN: 1436-6215
DOI
https://doi.org/10.1007/s00394-019-02039-9

Other articles of this Issue 5/2020

European Journal of Nutrition 5/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.